Immune cell therapy takes on tough blood cancers
NCT ID NCT03331198
First seen Jun 25, 2026 · Last updated Jul 07, 2026 · Updated 3 times
Summary
This study tests a treatment called JCAR017, a type of CAR T-cell therapy, for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to other treatments. The therapy uses a patient's own immune cells, which are modified in a lab to better attack cancer cells. The trial will test JCAR017 alone or combined with other drugs (ibrutinib or venetoclax) in about 320 adults to see if it is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- JCAR017 (lisocabtagene maraleucel), a CAR T-cell therapy, sometimes combined with ibrutinib or venetoclax
- What this could lead to
- If successful, this could offer a new treatment option for people with hard-to-treat CLL or SLL, potentially leading to long-term disease control.
- What could go wrong
- This is an early-phase trial (Phase 1/2), so the treatment may not work for everyone. CAR T-cell therapy can cause serious side effects like cytokine release syndrome or neurological problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
City of Hope
Duarte, California, 91010, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Local Institution - 0001
Basking Ridge, New Jersey, 07920, United States
-
Local Institution - 0002
Houston, Texas, 77030, United States
-
Local Institution - 0003
Chicago, Illinois, 60611, United States
-
Local Institution - 0005
Boston, Massachusetts, 02114, United States
-
Local Institution - 0006
Birmingham, Alabama, 35294, United States
-
Local Institution - 0007
Duarte, California, 91010, United States
-
Local Institution - 0008
Omaha, Nebraska, 68198, United States
-
Local Institution - 0010
San Francisco, California, 94143, United States
-
Local Institution - 0015
Boston, Massachusetts, 02215, United States
-
Local Institution - 0016
Chicago, Illinois, 60637, United States
-
Local Institution - 0018
Seattle, Washington, 98109, United States
-
Local Institution - 0019
Atlanta, Georgia, 30342, United States
-
Local Institution - 0025
La Jolla, California, 92093, United States
-
Local Institution - 0026
New York, New York, 10032, United States
-
Local Institution - 0027
New Orleans, Louisiana, 70112, United States
-
Local Institution - 0028
Salt Lake City, Utah, 84112, United States
-
Local Institution - 0029
Pittsburgh, Pennsylvania, 15232, United States
-
Local Institution - 0030
Durham, North Carolina, 27705, United States
-
Local Institution - 0031
Columbus, Ohio, 43210, United States
-
Local Institution - 0032
Philadelphia, Pennsylvania, 19107, United States
-
Local Institution - 0035
New York, New York, 10021, United States
-
Local Institution - 0038
Hackensack, New Jersey, 07601-2191, United States
-
Local Institution - 0043
Gilbert, Arizona, 85234, United States
-
Local Institution - 0054
Rochester, Minnesota, 55905, United States
-
Local Institution - 0055
Milwaukee, Wisconsin, 53226, United States
-
Local Institution - 0059
Los Angeles, California, 90095, United States
-
Local Institution - 0062
Detroit, Michigan, 48201, United States
-
Local Institution - 0064
Louisville, Kentucky, 40202, United States
-
Local Institution - 0077
New Brunswick, New Jersey, 08903, United States
-
Local Institution - 0078
Cleveland, Ohio, 44106, United States
-
Local Institution - 0079
Dallas, Texas, 75426, United States
-
Local Institution - 0080
Jacksonville, Florida, 32224, United States
-
Local Institution - 0082
Oklahoma City, Oklahoma, 73104, United States
-
Local Institution - 0083
Dallas, Texas, 75390, United States
-
Local Institution - 0084
Ann Arbor, Michigan, 48109, United States
-
Local Institution - 0085
Washington D.C., District of Columbia, 20007, United States
-
Local Institution - 0087
Richmond, Virginia, 23298, United States
-
Local Institution - 0088
Philadelphia, Pennsylvania, 19104, United States
-
Local Institution - 0089
Stony Brook, New York, 11794-8160, United States
-
Local Institution - 0098
Eugene, Oregon, 97401, United States
-
Local Institution - 0104
Atlanta, Georgia, 30322, United States
-
Local Institution - 0105
Indianapolis, Indiana, 46237, United States
-
Local Institution - 0106
Morristown, New Jersey, 07960, United States
-
Local Institution - 0107
Wichita, Kansas, 67124, United States
-
Local Institution - 0109
Detroit, Michigan, 48202, United States
-
Local Institution - 0111
Denver, Colorado, 80218, United States
-
Local Institution - 0112
Toronto, Ontario, M5G 2C1, Canada
-
Local Institution - 0114
Edison, New Jersey, 08820, United States
-
Local Institution - 0117
Chattanooga, Tennessee, 37403, United States
-
Local Institution - 0118
Winston-Salem, North Carolina, 27157, United States
-
Local Institution - 0119
Nashville, Tennessee, 37203, United States
-
Local Institution - 0120
Charlotte, North Carolina, 28204, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
The Blood and Marrow Transplant Group of Georgia (BMTGA)
Atlanta, Georgia, 30342, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
UC San Diego Moores Cancer Center
La Jolla, California, 92093, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
University Hospitals Seidman Cancer Center (Case Western)
Cleveland, Ohio, 44106-5061, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109-5362, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Oklahoma Health Sciences Center (Stephenson Cancer Center)
Oklahoma City, Oklahoma, 73104, United States
-
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, Pennsylvania, 19104, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
Weill Cornell Medical College
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for tough blood cancers: early trial of ONO-7018 begins
- New combo therapy for CLL tested in Real-World settings
- New CLL strategy: give extra drug only to those who still have cancer cells
- New pill shows promise for Hard-to-Treat blood cancers
- New pill shows promise for Hard-to-Treat leukemia and lymphoma
- Engineered immune cells take on tough leukemias